Commissioner Office Restructuring Heads List Of Possible FDA Changes
This article was originally published in The Tan Sheet
Executive Summary
The structure of the FDA commissioner's office is being evaluated by a four-person task group, FDA Associate Commissioner for Strategic Management Linda Suydam told the Food & Drug Law Institute's annual conference in Washington, D.C. Dec. 16.